• OPEN AN ACCOUNT
Indian Indices
Nifty
24,718.60 -169.60
(-0.68%)
Sensex
81,118.60 -573.38
( -0.70%)
Bank Nifty
55,527.35 -555.20
( -0.99%)
Nifty IT
38,469.25 8.95
( 0.02%)
Global Indices
Nasdaq
42,214.73 -773.90
(-1.80%)
Dow Jones
5,997.34 -68.92
(-1.14%)
Hang Seng
37,801.43 -371.66
(-0.97%)
Nikkei 225
8,850.63 -34.29
(-0.39%)
Forex
USD-INR
85.55 0.07
(0.08%)
EUR-INR
98.89 0.98
(1.00%)
GBP-INR
116.24 0.70
(0.61%)
JPY-INR
0.60 0.01
(0.86%)

EQUITY - MARKET SCREENER

Shukra Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524632
INE551C01044
1.4350513
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
66.45
640.18
EPS(TTM)
Face Value()
Div & Yield %
0.22
1
0
 

Shree Renuka Sugars reports consolidated net profit of Rs 91.60 crore in the March 2025 quarter
May 15,2025
Net profit of Shree Renuka Sugars reported to Rs 91.60 crore in the quarter ended March 2025 as against net loss of Rs 111.70 crore during the previous quarter ended March 2024. Sales declined 21.67% to Rs 2713.00 crore in the quarter ended March 2025 as against Rs 3463.50 crore during the previous quarter ended March 2024.

For the full year,net loss reported to Rs 299.80 crore in the year ended March 2025 as against net loss of Rs 627.20 crore during the previous year ended March 2024. Sales declined 6.29% to Rs 10589.10 crore in the year ended March 2025 as against Rs 11299.80 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales2713.003463.50 -22 10589.1011299.80 -6
OPM %10.767.44 -5.686.04 -
PBDT161.2024.80 550 -83.00-195.60 58
PBT90.90-44.10 LP -362.60-461.80 21
NP91.60-111.70 LP -299.80-627.20 52